Cargando…

Value of KPNA4 as a diagnostic and prognostic biomarker for hepatocellular carcinoma

It is important to identify novel biomarkers to improve hepatocellular carcinoma (HCC) diagnosis and treatment. Herein, we reported the role of karyopherin α4 (KPNA4) in HCC patients through public data mining and examined the results using clinical samples in our center. Our results revealed that K...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Mingxing, Liang, Hao, Li, Kun, Zhu, Shu, Yao, Zhicheng, Xu, Ruiyun, Lin, Nan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7950262/ https://www.ncbi.nlm.nih.gov/pubmed/33535183 http://dx.doi.org/10.18632/aging.202447

Ejemplares similares

Identification of CELSR2 as a novel prognostic biomarker for hepatocellular carcinoma
por: Xu, Mingxing, et al.
Publicado: (2020)

Identification of miRNAs as diagnostic and prognostic markers in hepatocellular carcinoma
por: Liang, Hao, et al.
Publicado: (2021)

Expression and prognostic roles of PRDXs gene family in hepatocellular carcinoma
por: Xu, Mingxing, et al.
Publicado: (2021)

Circ_0001955 facilitates hepatocellular carcinoma (HCC) tumorigenesis by sponging miR-516a-5p to release TRAF6 and MAPK11
por: Yao, Zhicheng, et al.
Publicado: (2019)

Diagnostic and prognostic values of AKR1C3 and AKR1D1 in hepatocellular carcinoma
por: Zhu, Pengfei, et al.
Publicado: (2021)

Distinct diagnostic and prognostic values of Glypicans gene expression in patients with hepatocellular carcinoma
por: Wang, Jian-Yao, et al.
Publicado: (2021)

Nuclear import of prototype foamy virus transactivator Bel1 is mediated by KPNA1, KPNA6 and KPNA7
por: Duan, Jihui, et al.
Publicado: (2017)

Nuclear import of prototype foamy virus transactivator Bel1 is mediated by KPNA1, KPNA6 and KPNA7
por: Duan, Jihui, et al.
Publicado: (2016)

Multiomics-based analyses of KPNA2 highlight its multiple potentials in hepatocellular carcinoma
por: Zhang, Jinzhong, et al.
Publicado: (2021)

Cell Cycle Genes Are Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma
por: Liping, Xu, et al.
Publicado: (2020)

Prognostic value of increased KPNA2 expression in some solid tumors: A systematic review and meta-analysis
por: Zhou, Li-Na, et al.
Publicado: (2016)

KPNA2-Associated Immune Analyses Highlight the Dysregulation and Prognostic Effects of GRB2, NRAS, and Their RNA-Binding Proteins in Hepatocellular Carcinoma
por: Zhang, Xiuzhi, et al.
Publicado: (2020)

Diagnostic and prognostic value of MCM3 and its interacting proteins in hepatocellular carcinoma
por: Li, Hong-Tao, et al.
Publicado: (2020)

Prognostic value of inflammatory and nutritional markers for hepatocellular carcinoma
por: Xu, Yingying, et al.
Publicado: (2021)

Prognostic and diagnostic value of SOX9 in cirrhotic and noncirrhotic hepatocellular carcinoma
por: Xu, Zhong-Ping, et al.
Publicado: (2021)

Antiviral therapy predicts the outcomes following resection of hepatocellular carcinoma in patients negative for HBV DNA: a propensity score matching analysis
por: Xu, Mingxing, et al.
Publicado: (2019)

Diagnostic and prognostic value of circular RNAs in hepatocellular carcinoma
por: Sun, Jin‐Yu, et al.
Publicado: (2020)

Diagnostic and Prognostic Values of MANF Expression in Hepatocellular Carcinoma
por: He, Jingyi, et al.
Publicado: (2020)

KCNK levels are prognostic and diagnostic markers for hepatocellular carcinoma
por: Li, Wen-Chao, et al.
Publicado: (2019)

Mechanism of exosomal microRNA-224 in development of hepatocellular carcinoma and its diagnostic and prognostic value
por: Cui, Yao, et al.
Publicado: (2019)

Diagnostic and Prognostic Value of Protein Post-translational Modifications in Hepatocellular Carcinoma
por: Wang, Jing, et al.
Publicado: (2023)

Laparoscopic RFA with splenectomy for hepatocellular carcinoma
por: Hu, Kunpeng, et al.
Publicado: (2016)

Oncogenic KPNA2 Serves as a Biomarker and Immune Infiltration in Patients With HPV Positive Tongue Squamous Cell Carcinoma
por: Gao, Li, et al.
Publicado: (2022)

Diagnostic and Prognostic Nomograms for Hepatocellular Carcinoma Based on PIVKA-II and Serum Biomarkers
por: An, Shu, et al.
Publicado: (2023)

GDI2 is a novel diagnostic and prognostic biomarker in hepatocellular carcinoma
por: Zhang, Wen, et al.
Publicado: (2021)

KPNA3 Confers Sorafenib Resistance to Advanced Hepatocellular Carcinoma via TWIST Regulated Epithelial-Mesenchymal Transition
por: Hu, Bo, et al.
Publicado: (2019)

The diagnostic and prognostic value of cell division cycle associated gene family in Hepatocellular Carcinoma
por: Wu, Bowen, et al.
Publicado: (2020)

Corrigendum to “Cell Cycle Genes Are Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma”
por: Liping, Xu, et al.
Publicado: (2020)

The diagnostic and prognostic value of H2AFY in hepatocellular carcinoma
por: Ma, Xuyang, et al.
Publicado: (2021)

Diagnostic and prognostic values of pyroptosis-related genes for the hepatocellular carcinoma
por: Xing, Mindan, et al.
Publicado: (2022)

Members of the Chromobox Family Have Prognostic Value in Hepatocellular Carcinoma
por: Pan, Chenxi, et al.
Publicado: (2022)

Promising Novel Biomarkers for Hepatocellular Carcinoma: Diagnostic and Prognostic Insights
por: Yu, James, et al.
Publicado: (2023)

The functional role of the novel biomarker karyopherin α 2 (KPNA2) in cancer
por: Christiansen, Anders, et al.
Publicado: (2013)

Distinct Diagnostic and Prognostic Values of Minichromosome Maintenance Gene Expression in Patients with Hepatocellular Carcinoma
por: Liao, Xiwen, et al.
Publicado: (2018)

Promising diagnostic and prognostic value of E2Fs in human hepatocellular carcinoma
por: Huang, Yan-Lin, et al.
Publicado: (2019)

Diagnostic Value of Immunological Biomarkers in Children with Asthmatic Bronchitis and Asthma
por: Wu, Ming, et al.
Publicado: (2023)

Prognostic value of glucose transporter 3 expression in hepatocellular carcinoma
por: Gao, Hengjun, et al.
Publicado: (2020)

Diagnostic and prognostic values of upregulated SPC25 in patients with hepatocellular carcinoma
por: Yang, Xiaolin, et al.
Publicado: (2020)

The Diagnostic Value of MicroRNAs as a Biomarker for Hepatocellular Carcinoma: A Meta-Analysis
por: Jiang, Yao, et al.
Publicado: (2019)

Clinical and Prognostic Biomarker Value of Blood-Circulating Inflammatory Cytokines in Hepatocellular Carcinoma
por: Chamseddine, Shadi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ldemq41h8tnk3robs2dkmnc6k7